We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI-Related Patents Issued to Biophan

By MedImaging staff writers
Posted on 02 Sep 2005
Biophan Technologies, Inc. (Rochester, NY, USA) has two new U.S patents issued to the company, while one U.S. patent has been issued to Nanoset, LLC (East Rochester, NY, USA), a technology collaborator that has granted Biophan exclusive worldwide medical rights to the patent.

These newly issued patents increase Biophan's intellectual property portfolio to 144 U.S. patients, applications, or licenses. "These patents can provide improved capabilities to a wide variety of devices, increasing the technologies we have to offer,” said Michael Weiner, CEO of Biophan. "This fits with our strategy of providing enabling technology to many device manufacturers.”

One patent covers cardiac-assist devices designed to be compatible with magnetic resonance imaging (MRI), when MRI signals are detected, so that the communications circuit between the heart and the device can be interrupted, to avoid the possible hazards of tissue heating and induced voltages. Sensing the MRI unit's excitation signal by use of an opto-electronic device is covered by this patent. This is one of several approaches to address the problems of MRI safety and cardiac-assist devices such as defibrillators and pacemakers.

"In [another patent,] we teach how to convert electrical information, including radio waves, into optical signals to move them along an optical fiber, when used in conjunction with MRI,” Mr. Weiner added. "MRI provides the advantage of superior tissue imaging with no exposure to potentially harmful ionizing radiation. The technology also has potential applications for oncology, diabetes, and other diseases.”

The third patent covers almost any medical conductor, including a defibrillator, pacemaker, or neurostimulator lead, that includes nonmagnetic coatings and is designed to be flexible.

Biophan recently completed a licensing agreement and received an equity investment from Boston Scientific (Natick, MA, USA). Under the agreement, Boston Scientific receives specific licensing rights within certain product categories to these and other Biophan and Nanoset patents.



Related Links:
Biophan Technologies, Inc
Multi-Use Ultrasound Table
Clinton
Adjustable Mobile Barrier
M-458
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Ultrasonic Pocket Doppler
SD1

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.